共 91 条
[1]
Ashina M(2020)Migraine N Engl J Med 383 1866-1876
[2]
Ailani J(2021)The American Headache Society consensus statement: update on integrating new migraine treatments into clinical practice Headache 61 1021-1039
[3]
Burch RC(2019)The American Headache Society position statement on integrating new migraine treatments into clinical practice Headache 59 1-18
[4]
Robbins MS(2021)Diagnosis and management of migraine in ten steps Nat Rev Neurol 17 501-514
[5]
Eigenbrodt AK(2020)Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial Lancet Neurol 19 727-737
[6]
Ashina H(2021)Atogepant for the preventive treatment of migraine N Engl J Med 385 695-706
[7]
Khan S(2023)Once-daily oral atogepant for the long-term preventive treatment of migraine: findings from a multicenter, randomized, open-label, phase 3 trial Headache 63 79-88
[8]
Diener HC(2019)CGRP—a target for acute therapy in migraine: clinical data Cephalalgia 39 420-427
[9]
Mitsikostas DD(2012)CGRP receptor antagonists: an expanding drug class for acute migraine? Expert Opin Investig Drugs 21 807-818
[10]
Sinclair AJ(2022)Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up Study Neurology 99 e1897-e1904